Posts

R Package Submission to CRAN I just submitted an R package, prewas, that I wrote with my colleagues Zena and Stephanie. The whole process took many more hours than I had anticipated. This post details the snags I ran into and their fixes. Hopefully, this will help other package submission newbies! General resources: There are many resources that spell most of what you need to know to submit a package.

CONTINUE READING

Market Sizing I created an interactive dashboard to facilitate with market sizing. Here is a static image of the dashboard: Users can estimate the market size of a product, company or industry using a bottom up approach. The dashboard dynamically generates the plot with the relative sizes of the total available market (TAM), serviceable available market (SAM), and serviceable obtainable market (SOM). Users can download a .png of the plot.

CONTINUE READING

Emoji DNA Generate a DNA string of two random emoji each time your terminal starts, like this adorable koala-bear DNA: Download the script from my github page. To use emoji_dna.sh: 1) Download emoji_dna.sh 2) From your terminal add to your bash_profile (nano ~/.bash_profile) the line: bash /path/to/emoji_dna.sh 3) Source your bash_profile: source ~/.bash_profile 4) Open a new terminal window and enjoy! This little script was a challenge put to me by Ryan Crawford while we discussed both the elegant Bonsai tree generator for terminal by John Allbritten and the goofy twitter account @emojiDNA.

CONTINUE READING

Locations in The Dresden Files The Dresden Files are an amazing, silly fantasy series about magic in modern day Chicago. This tutorial will walk through how to makes maps in R using locations from The Dresden Files. Getting location data I had a ton of fun clicking around this interactive map of The Dresden Files locations. I wanted to expand on it by including more locations and adding metadata onto the locations.

CONTINUE READING

If you’re nervous about an upcoming poster session it may help to articulate your specific concerns, develop a strategy to address each one, and then proceed to have a great poster session. Here are some common concerns and my suggested strategies. Concerns about presenting unpublished or unfinished work Fear 1: The project is unfinished so people will ask questions I can’t answer. You are presenting work that isn’t yet published so there will be gaps in your research.

CONTINUE READING

Presenting your research at a poster session is a learned skilled. If you find it hard the first time don’t panic, you just need some practice and a little help. I used to get a stomach ache just thinking about presenting at a poster session. Now I look forward to them and leave more energized about my research. Here are the steps I took to improve my poster session experience.

CONTINUE READING

I’ve written an open R software package to perform bacterial genome-wide association studies. Read the wiki to learn about it, download the package (instructions here), and take it for a spin!

It’s called hogwash. hoGWASh. Get it?! Tough crowd.

CONTINUE READING

The Venture Capital Competition for Graduate Students The Venture Capital Investment Competition is the “world’s largest venture capital competition with over 70 universities competing. VCIC is the only place where students get to be VCs for the day” Although I’m sure student funds, such as the Dorm Room Fund and Contrary Capital, would argue that students can be investors while still in school. In the competition each university team hears pitches from three businesses and drafts a term sheet for the most promising venture.

CONTINUE READING

Healthcare fortunes at stake during conference The J. P. Morgan Healthcare Conference (JPMHC) is an annual get together of pharma and biotech bigwigs in San Francisco. It’s considered common knowledge that stocks change in response to the speeches, deals, and data presented at the meeting. One article said that: “Biotech has historically outperformed the broader market during The J.P. Morgan Healthcare Conference” and “in the past 16 years, the NYSE Arca Biotechnology index (BTK), which measures the performance of 30 biotechnology firms, has outperformed the S&P 500 index by nearly 3 percent during JPMorgan’s conference.

CONTINUE READING